Molybdenum-based hetero-nanocomposites for cancer therapy, diagnosis and biosensing application : Current advancement and future breakthroughs
Copyright © 2020 Elsevier B.V. All rights reserved..
In recent years, there have been significant advancements in the nanotechnology for cancer therapy. Even though molybdenum disulphide (MoS2)-based nanocomposites demonstrated extensive applications in biosensing, bioimaging, phototherapy, the review article focusing on MoS2 nanocomposite platform has not been accounted for yet. The review summarizes recent strategies on design and fabrication of MoS2-based nanocomposites and their modulated properties in cancer treatment. The review also discussed several therapeutic strategies (photothermal, photodynamic, immunotherapy, gene therapy and chemotherapy) and their combinations for efficient cancer therapy along with certain case studies. The review also inculcates various diagnostic techniques viz. magnetic resonance imaging, computed tomography, photoacoustic imaging and fluorescence imaging for diagnosis of cancer.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:330 |
|---|---|
| Enthalten in: |
Journal of controlled release : official journal of the Controlled Release Society - 330(2021) vom: 10. Feb., Seite 257-283 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Dhas, Namdev [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 07.07.2021 Date Revised 07.07.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jconrel.2020.12.015 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM319106608 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM319106608 | ||
| 003 | DE-627 | ||
| 005 | 20231225170741.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jconrel.2020.12.015 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1063.xml |
| 035 | |a (DE-627)NLM319106608 | ||
| 035 | |a (NLM)33345832 | ||
| 035 | |a (PII)S0168-3659(20)30739-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Dhas, Namdev |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Molybdenum-based hetero-nanocomposites for cancer therapy, diagnosis and biosensing application |b Current advancement and future breakthroughs |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 07.07.2021 | ||
| 500 | |a Date Revised 07.07.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 Elsevier B.V. All rights reserved. | ||
| 520 | |a In recent years, there have been significant advancements in the nanotechnology for cancer therapy. Even though molybdenum disulphide (MoS2)-based nanocomposites demonstrated extensive applications in biosensing, bioimaging, phototherapy, the review article focusing on MoS2 nanocomposite platform has not been accounted for yet. The review summarizes recent strategies on design and fabrication of MoS2-based nanocomposites and their modulated properties in cancer treatment. The review also discussed several therapeutic strategies (photothermal, photodynamic, immunotherapy, gene therapy and chemotherapy) and their combinations for efficient cancer therapy along with certain case studies. The review also inculcates various diagnostic techniques viz. magnetic resonance imaging, computed tomography, photoacoustic imaging and fluorescence imaging for diagnosis of cancer | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Biomedical applications | |
| 650 | 4 | |a Chemotherapy | |
| 650 | 4 | |a Magnetic resonance imaging | |
| 650 | 4 | |a Molybdenum disulphide | |
| 650 | 4 | |a Photoacoustic imaging | |
| 650 | 4 | |a Phototherapy | |
| 650 | 7 | |a Disulfides |2 NLM | |
| 650 | 7 | |a Molybdenum |2 NLM | |
| 650 | 7 | |a 81AH48963U |2 NLM | |
| 700 | 1 | |a Kudarha, Ritu |e verfasserin |4 aut | |
| 700 | 1 | |a Garkal, Atul |e verfasserin |4 aut | |
| 700 | 1 | |a Ghate, Vivek |e verfasserin |4 aut | |
| 700 | 1 | |a Sharma, Shilpa |e verfasserin |4 aut | |
| 700 | 1 | |a Panzade, Prabhakar |e verfasserin |4 aut | |
| 700 | 1 | |a Khot, Shubham |e verfasserin |4 aut | |
| 700 | 1 | |a Chaudhari, Pinal |e verfasserin |4 aut | |
| 700 | 1 | |a Singh, Ashutosh |e verfasserin |4 aut | |
| 700 | 1 | |a Paryani, Mitali |e verfasserin |4 aut | |
| 700 | 1 | |a Lewis, Shaila |e verfasserin |4 aut | |
| 700 | 1 | |a Garg, Neha |e verfasserin |4 aut | |
| 700 | 1 | |a Singh, Narinder |e verfasserin |4 aut | |
| 700 | 1 | |a Bangar, Priyanka |e verfasserin |4 aut | |
| 700 | 1 | |a Mehta, Tejal |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of controlled release : official journal of the Controlled Release Society |d 1996 |g 330(2021) vom: 10. Feb., Seite 257-283 |w (DE-627)NLM085820296 |x 1873-4995 |7 nnns |
| 773 | 1 | 8 | |g volume:330 |g year:2021 |g day:10 |g month:02 |g pages:257-283 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jconrel.2020.12.015 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 330 |j 2021 |b 10 |c 02 |h 257-283 | ||